1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-N~6~-[(4-methylphenyl)sulfonyl]lysylglycinamide,39028-45-0 Products Supply

Name: 1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-N~6~-[(4-methylphenyl)sulfonyl]lysylglycinamide
CAS NO.: 39028-45-0
Synonyms:
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n6-[(4-methylphenyl)sulfonyllysylglycinamide;AC1L4RMW;AC1Q5JBZ;AR-1B9633;(1-beta-Mercaptopropionic acid,8(epsilon-N-4-toluenesulfonyl)lysine)vasopressin;Vasopressin, (1-beta-mercapto-propionic acid,8(epsilon-N-4-toluenesulfonyl)lysine)-;Vasopressin, (1-beta-mercaptopropionic-acid,8(epsilon-N-p-toluenesulfonyl)lysine)-;Vasopressin, (1beta-mercaptopropionic acid,8(epsilon-N-4-toluenesulfonyl)lys)-;Vasopressin, 1-(3-mercaptopropanoic acid)-8-(N(6)-((4-methylphenyl)sulfonyl)-L-lysine)-;N-[1-[(2-amino-2-oxoethyl)amino]-6-[(4-methylphenyl)sulfonylamino]-1-oxohexan-2-yl]-1-[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
Molecular Structure:
Molecular Formula: C₅₃H₇₀N₁₂O₁₄S₃

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[11-(2-amino-2-oxoethyl)-8-; 1-{[(4R,7S,10S,13R,16S,19R)-19; 1-{[(4R,7S,10S,13S,16S)-7-(2-a; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[(4R,7S,10S,13R,16S,19R)-19; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,16S)-7-(2-amino; 1-{[7-(2-amino-2-oxoethyl)-13-; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-({(4S,7S,10S,16S)-7-(2-amino; 1-{[7-(2-amino-2-oxoethyl)-10-; 1/C11H14N2O6/c1-17-7(14)4-12-2; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(2S,8S,11S,14S,19S)-19-ami; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1/C14H16O4/c1-5-10-12-9(14(15); 1/C12H10N4O3/c1-3-19-12(18)10-; N-{[(2S)-1-{[(4R,7S,10S,16S,19; 1-{[(4R,7S,10S,16S,19R)-7-(2-a; 1/C15H13NO/c1-2-16-14-6-4-3-5-; 1/C14H9Br2O2P/c15-11-6-8-13(17; 1/C14H15O3P/c15-18(16-11-13-7-;